Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALSUntangled does not recommend Basis for treating ALS

Original source

BasisALSUntangled · 18 September 2017 (opens in a new tab)

ALSUntangled reviewed Basis and found theoretical mechanisms that could be relevant to amyotrophic lateral sclerosis (ALS). It found no studies in ALS models, case reports, or trials involving people with ALS, and therefore does not recommend Basis to slow, stop, or reverse ALS progression.

Why this matters

This review does not provide evidence that Basis benefits people with ALS or changes treatment decisions. The available evidence is limited to a small, short study in healthy volunteers, which assessed safety rather than treatment effectiveness in ALS.

Limitations and context

This is an expert review from ALSUntangled, not a clinical trial or primary research study. The review reported no preclinical ALS data, case reports, or trials in people with ALS, so whether Basis is effective or safe for treating ALS remains unknown.

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?